Prognostic factors of brain metastasis and subsequent survival in breast cancer patients: An 11-year, single-center, retrospective study.

Medicine (Baltimore) · 2025 · PMC11922408 · PMID 40101072

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP = .100so close (0.05 < p ≤ 0.1)

Interestingly, patients with HER2-overexpressing breast cancer exhibited a longer median survival compared to those without overexpression (12.3 vs 5.9 months), although this difference did not reach statistical significance ( P = .100).

also in 111,027 other papers

showed a trendno p-value reported

[ 11 ] In this study, bone metastasis was not an independent prognostic factor in the multivariate analysis, although it showed a trend of poor prognosis in the univariate analysis.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.